Eight patients received brain transplants of lab-grown dopamine cells. A year later, here's exactly what the peer-reviewed data shows, and what it doesn't.
Jul 30, 2026
•
4 min read
A Boston biotech just dosed the first human with a therapy meant to reset a cell's biological age. Here's what was actually shown, and what wasn't.
Jul 23, 2026
5 min read
In March, Japan approved the world's first iPSC-derived therapies. Here is what the evidence behind that approval actually looks like.
May 7, 2026
6 min read
What "approved" actually means. And what it doesn't
Mar 25, 2026
8 min read
